Heparin

Preview FDA label, Hospira, Inc., intravenous, effective 2026-05-12. Full label on DailyMed

Quoted from the FDA label. Product labels differ by manufacturer and change over time; confirm against the label for the product you are using. Not yet reviewed by a ClinDose pharmacist.

Dosing in kidney impairment

Extracorporeal Dialysis Follow equipment manufacturer's operating directions carefully. A dose of 25 units/kg to 30 units/kg followed by an infusion rate of 1,500 units/hour to 2,000 units/hour is suggested based on pharmacodynamic data if specific manufacturers' recommendations are not available.

For pediatric dosing see section 2.4 of full prescribing information.
Intravascular via Extracorporeal DialysisFollow equipment manufacturer's operating directions carefully.

Preparation and administration

Preparation for Administration Confirm the selection of the correct formulation and strength prior to administration of the drug. Do not use HEPARIN SODIUM IN SODIUM CHLORIDE INJECTION as a "catheter lock flush" product. Administer this product by intravenous infusion. Do not admix with other drugs. This product should not be infused under pressure.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not administer unless the solution is clear and container is undamaged. Discard unused portion. To Open Tear outer wrap and remove solution container. For PVC bags, some opacity of the plastic due to moisture absorption during the sterilization process may be observed.

This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. (Use aseptic technique) 1. Close flow control clamp of administration set. 2. Remove cover from outlet port at bottom of container. 3. Insert piercing pin of administration set into port with a twisting motion until the set is firmly seated.

NOTE: See full directions on administration set carton. 4. Suspend container from hanger. 5. Squeeze and release drip chamber to establish proper fluid level in chamber. 6. Open flow control clamp and clear air from set. Close clamp. 7. Attach set to venipuncture device. If device is not indwelling, prime and make venipuncture. 8.

Regulate rate of administration with flow control clamp. Warning: Do not use flexible container in series connections.

Intermittent Intravenous InjectionInitial Dose 10,000 Units
Every 4 to 6 hours5,000 Units to 10,000 Units
Continuous Intravenous InfusionInitial Dose5,000 Units
Continuous20,000 Units to 40,000 Units/24 hours
*Based on 150 lb (68 kg) patient.
Table 1: Recommended Adult Full-Dose Heparin Regimens for Therapeutic Anticoagulant Effect
Method of AdministrationFrequencyRecommended DoseBased on 150 lb. (68 kg) patient.
Intermittent Intravenous InjectionInitial Dose10,000 Units
Every 4 to 6 hours5,000 Units to 10,000 Units
Continuous Intravenous InfusionInitial Dose5,000 Units by intravenous injection
Continuous20,000 Units/24 hours to 40,000 Units/24 hours
Initial Dose75 units/kg to 100 units/kg (intravenous bolus over 10 minutes)
Maintenance DoseInfants: 25 units/kg/hour to 30 units/kg/hour (continuous intravenous infusion); Infants less than 2 months have the highest requirements (average 28 units/kg/hour) Children greater than 1 year of age: 18 units/kg/hour to 20 units/kg/hour (continuous intravenous infusion); Older children may require less heparin, similar to weight-adjusted adult dosage.
Monitoring Adjust heparin to maintain APTT of 60 seconds to 85 seconds, assuming this reflects an anti-Factor Xa level of 0.35 to 0.70.